This is particularly relevant in OMM, where mutation rates differ significantly from cutaneous melanoma; for instance, KIT mutations may occur in up to 25% of cases, while BRAF mutations are uncommon (<6%) [27]. This evidence concerns the gene KIT and cutaneous melanoma.